Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Somalia set for 'historic' first offshore oil drilling - 2Obamacare enrollment declines as US subsidies expire
- 3What are parents to do as doctors clash with Trump administration over vaccines?
- 4AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
- 5What to know about the hepatitis B shot — and why Trump officials are targeting it
- December’s full moon is the last supermoon of the year. Here’s what to know
- American Airlines Flight Attendant Disappears Amid Layover in Colombia, Authorities Investigating
- Shredded cheese sold in dozens of states recalled due to potential for metal fragment contamination
- WHO issues guidance on GLP-1 drugs for obesity
- The Benefits of Effective money management for Your Youngsters' Future Monetary Prosperity
- Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it
- Etymological Investigation Disclosed: A Survey of \Dominating New Tongues\ Language Learning Application
- Two Endangered Bengal Tiger Cubs Die Days Apart at Zoo After Contracting Virus
- The Best Web-based Courses for Ability Advancement
